# PolyPeptide Laboratories, Inc. – FDA Inspection, Feb 22, 2012

Source: https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/8a26e902-6fa3-4a52-999b-259c916ee205
Source feed: FDA_Inspections

> FDA inspection 770485 of PolyPeptide Laboratories, Inc., February 22, 2012. Classification: Voluntary Action Indicated (VAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 770485
- Company Name: PolyPeptide Laboratories, Inc.
- Inspection Date: 2012-02-22
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1246171 - 2024-05-10](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/f50ba29e-e3b8-44a9-a050-0b7c0ebf6f77)
- [FDA Inspection 1159374 - 2021-11-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/af021466-df72-405e-9b69-bdd15df330cb)
- [FDA Inspection 1103072 - 2019-08-30](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/f8241a25-900b-41ee-ac9d-b8177058c42d)
- [FDA Inspection 1021060 - 2017-07-19](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/bb82abf9-badf-4502-823c-de13bd77dffb)
- [FDA Inspection 953881 - 2015-12-03](https://www.keypedia.com/records/fda_inspections/polypeptide-laboratories-inc/d741dbc5-ed38-47f1-9fa7-51aa6f144e90)

Company: https://www.keypedia.com/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c